Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

How clickbait headlines affect prostate cancer diagnosis and management

Matthew N. Simmons, MD, PhD
Conditions
October 6, 2016
Share
Tweet
Share

Our culture has taken a strange turn where the truth is relative, and where conspiracy theories rule the day. News sources and social networks are rife with political agendas, fake articles, and disguised advertisements. This chaos harms our social welfare, but can also impact physical health. Misleading news reports of new clinical studies make it difficult to discern medical fact from fiction.

I spend hours in clinic justifying recommendations to patients when they conflict with something they read on Facebook. Some patients think I have a hidden agenda or think I am ignorant and uninformed. In principle, I adhere to evidence-based practices and professional guidelines, however antiquated that may seem.

Given that a major part of my practice is prostate cancer I am especially impacted by media effects. In 2012 the U.S. Preventative Services Task Force (USPSTF) recommended against PSA screening for prostate cancer. The Associated Press headline at that time announced: “Routine Prostate Cancer Test Not Recommended.” That recommendation was based on 2 clinical trials that compared prostate cancer deaths in men who underwent “routine screening” versus “usual treatment.” It was recently shown that 90 percent of patients in the “usual treatment” group had PSA testing. Based on this, it is not valid to conclude that there is no benefit to screening. One would expect that the USPSTF would have issued a retraction, and that the press would have criticized the USPSTF’s methods. Alas, there has been little mention of the issue, and PSA screening continues to be held in exile.

Another screening modality currently in jeopardy is the digital rectal exam (DRE). The Huffington Post website posted ,“The Most Common Prostate Cancer Screening Method is Obsolete.” This was based on a weak study published in Current Medical Research and Opinion that concluded that DRE exposed men to uncomfortable examinations for minimal gain. There is a large body of evidence supporting the importance of the DRE. Nonetheless, the media selected this one limited study as proof that it is all wrong.

Finally, treatment for prostate cancer is under attack. CBS news proclaimed: “Study: No Evidence that Treating Prostate Cancer Makes a Difference.” This was in response to a New England Journal of Medicine report that examined death rates in men with localized prostate cancer randomized to monitoring, prostatectomy or radiation. The study showed no difference in cancer-related death among the groups, but it did show that treatment lowered the incidence of metastasis. Minimal emphasis was placed on that benefit. In that study, 76 percent of men had low-risk disease. We know that low-risk prostate cancers pose a low risk for death, so findings of the study were not surprising. However, the headline implies that the results apply to all prostate cancers, which is not true. Men with intermediate and high-risk disease who avoid treatment run a much higher risk of dying from their disease.

One day this situation will be a case study on how inaccurate reporting by the media can cause a health hazard. Sensational headlines generate “clicks” and “likes,” the measure of success in today’s news business. Study limitations or nuances may be reported, but readers are immediately biased by the tone of the headline. The current theme regarding prostate cancer in the press is, “Don’t look for it and don’t treat it.” Headlines need to be less biased, and articles need to be more balanced and objective. Since 2012, more men have presented with high-risk and metastatic disease. Many men will die as a direct result of bad information.

Blame also lies partly with urologists. Overtreatment of prostate cancer has historically been a real issue. The USPSTF recommendation and other reports strengthen the public perception that urologists have conspired to profit off a harmless disease. It needs to be clearly emphasized that prostate cancer is dangerous and kills 26,000 men annually. We need to communicate how new genetic tests, imaging studies and treatment strategies are transforming the way we manage prostate cancer. We also need to improve the scientific quality of clinical studies, and there should be a policy whereby medical experts coordinate with news agencies to more accurately report study findings. The medical establishment needs to provide a sanctuary for facts in this world of uncertainty.

Matthew N. Simmons is a urologist.

Image credit: Shutterstock.com

Prev

Evidence should not be used to enforce mandates

October 5, 2016 Kevin 0
…
Next

Making pain a vital sign caused the opioid crisis. Here's how.

October 6, 2016 Kevin 14
…

Tagged as: Oncology/Hematology

Post navigation

< Previous Post
Evidence should not be used to enforce mandates
Next Post >
Making pain a vital sign caused the opioid crisis. Here's how.

ADVERTISEMENT

Related Posts

  • Hormone replacement therapy is still linked to cancer

    Martha Rosenberg
  • We have a shot at preventing cervical cancer

    Lisa N. Abaid, MD, MPH
  • Obstruction of medical justice: How health care fails patients with cancer

    Miriam A. Knoll, MD
  • Despite progress in cancer care, cost and equity challenges still must be addressed

    David M. Aboulafia, MD
  • Using the Avengers to explain how cancer treatments work

    Jennifer Lycette, MD
  • Is social media a friend or foe of science?

    Michael Joyce, MD

More in Conditions

  • Coconut oil’s role in Alzheimer’s and depression

    Marc Arginteanu, MD
  • Ancient health secrets for modern life

    Larry Kaskel, MD
  • How the internet broke the doctor-parent trust

    Wendy L. Hunter, MD
  • Mpox isn’t over: A silent epidemic is growing

    Melvin Sanicas, MD
  • How your family system secretly shapes your health

    Su Yeong Kim, PhD
  • The human case for preserving the nipple after mastectomy

    Thomas Amburn, MD
  • Most Popular

  • Past Week

    • The human case for preserving the nipple after mastectomy

      Thomas Amburn, MD | Conditions
    • Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims

      Robert E. White, Jr. & The Doctors Company | Policy
    • How new loan caps could destroy diversity in medical education

      Caleb Andrus-Gazyeva | Policy
    • IMGs are the future of U.S. primary care

      Adam Brandon Bondoc, MD | Physician
    • My first week on night float as a medical student

      Amish Jain | Education
    • From nurse practitioner to leader in quality improvement [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • Love, birds, and fries: a story of innocence and connection

      Dr. Damane Zehra | Physician
  • Recent Posts

    • My first week on night float as a medical student

      Amish Jain | Education
    • What Beauty and the Beast taught me about risk

      Jayson Greenberg, MD | Physician
    • Creating safe, authentic group experiences

      Diane W. Shannon, MD, MPH | Physician
    • The diseconomics of scale: How Indian pharma’s race to scale backfires on U.S. patients

      Adwait Chafale | Meds
    • Healing from medical training by learning to trust your body again [PODCAST]

      The Podcast by KevinMD | Podcast
    • How tragedy shaped a medical career

      Ronald L. Lindsay, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 2 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The human case for preserving the nipple after mastectomy

      Thomas Amburn, MD | Conditions
    • Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims

      Robert E. White, Jr. & The Doctors Company | Policy
    • How new loan caps could destroy diversity in medical education

      Caleb Andrus-Gazyeva | Policy
    • IMGs are the future of U.S. primary care

      Adam Brandon Bondoc, MD | Physician
    • My first week on night float as a medical student

      Amish Jain | Education
    • From nurse practitioner to leader in quality improvement [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • Love, birds, and fries: a story of innocence and connection

      Dr. Damane Zehra | Physician
  • Recent Posts

    • My first week on night float as a medical student

      Amish Jain | Education
    • What Beauty and the Beast taught me about risk

      Jayson Greenberg, MD | Physician
    • Creating safe, authentic group experiences

      Diane W. Shannon, MD, MPH | Physician
    • The diseconomics of scale: How Indian pharma’s race to scale backfires on U.S. patients

      Adwait Chafale | Meds
    • Healing from medical training by learning to trust your body again [PODCAST]

      The Podcast by KevinMD | Podcast
    • How tragedy shaped a medical career

      Ronald L. Lindsay, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

How clickbait headlines affect prostate cancer diagnosis and management
2 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...